Carregando...
Golimumab for Rheumatoid Arthritis
Since the advent of infliximab for the treatment of rheumatoid arthritis (RA), new genetically-engineered molecules have appeared. This review aims to present the current data and body of evidence for golimumab (GLM). Safety, efficacy, tolerability and immunogenicity are all being investigated, not...
Na minha lista:
| Publicado no: | J Clin Med |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463251/ https://ncbi.nlm.nih.gov/pubmed/30897745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8030387 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|